Business description
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. Novartis products are sold in approximately 155 countries around the world.
Management board & Supervisory board
| CEO |
| Vasant Narasimhan, M.D. |
| Management board |
| Harry Kirsch, Shreeram Aradhye, Victor Bulto, Aharon (Ronny) Gal, Karen L. Hale, Patrick Horber, Rob Kowalski, Dr. Steffen Lang, Dr. Fiona H. Marshall, Dr. Klaus Moosmayer |
| Supervisory board |
| Giovanni Caforio, Dr. Nancy C. Andrews, Ton Buechner, Elizabeth Doherty, Bridgette Heller, Daniel Hochstrasser, Frans van Houten, Simon Moroney, Ana de Pro Gonzalo, John D. Young, Elizabeth McNally , Patrice Bula, Dr. Charlotte Pamer-Wieser |
Company data
| Name: |
Novartis AG |
| Address: |
Lichtstrasse 35,CH-4002 Basel |
| Phone: |
+41-61-324-1111 |
| Fax: |
+41-61-324-8001 |
| E-mail: |
-
|
| Internet: |
www.novartis.com |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12/31 |
| Free Float: |
86.85% |
| IPO date: |
3/7/1996 |
